BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Drug Development

  FINOX Biotech Relaese: r-FSH Biosimilar Meets Primary Endpoint in Phase III Pivotal Study

  June 6, 2012

   · 

  3 min read
• Drug Development

  Rhythm Initiates Phase 2 Clinical Trial of Ghrelin Prokinetic RM-131 for Diabetic Gastroparesis

  June 6, 2012

   · 

  2 min read
• American Society of Clinical Oncology 2012: Show Me the Overall Survival Data!

  June 6, 2012

   · 

  6 min read
• Drug Development

  Savient Pharmaceuticals, Inc. Release: New Analysis of Phase III Trials Shows Gout Patients with Chronic Kidney Disease at Any Stage Responded to KRYSTEXXA® Presented in Oral Session at EULAR 2012

  June 6, 2012

   · 

  10 min read
• Pharm Country

  Brain Tumor Biotech Summit 2012 at Weill Cornell Medical College

  June 6, 2012

   · 

  5 min read
• BioCapital

  The Foundation for the National Institutes of Health (NIH) Announces Inaugural Lurie Prize to be Given to a Promising Scientist in Biomedical Research

  June 6, 2012

   · 

  3 min read
• 3SBio Inc. to Present at the BofAML HK / China Healthcare Corporate Day

  June 6, 2012

   · 

  1 min read
• Drug Development

  Abbott Laboratories Announces 10-Year Data Evaluating HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis

  June 6, 2012

   · 

  8 min read
• Syneron Medical Ltd. Announces International Launch of the ePlus(TM) Complete Aesthetic Work Station

  June 6, 2012

   · 

  3 min read
• Business

  Fluxion Biosciences and Rubicon Genomics, Inc. to Collaborate on Circulating Tumor Cell Applications

  June 6, 2012

   · 

  1 min read